株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

分子診断の世界市場の分析と予測

Global Molecular Diagnostics Market Research and Forecast, 2018-2023

発行 Orion Market Research Pvt Ltd 商品コード 785704
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
分子診断の世界市場の分析と予測 Global Molecular Diagnostics Market Research and Forecast, 2018-2023
出版日: 2019年01月21日 ページ情報: 英文
概要

当レポートでは、世界の分子診断市場の現状と見通しについて分析し、診断技術・関連疾患の概要や、市場の基本構造、外部からのマクロ的・ミクロ的影響、主な促進・抑制要因、世界全体および地域別の市場動向の見通し (今後6年間分)、セグメント別 (技術、製品、用途、エンドユーザーなど)の詳細動向、最新の市場競争状況、主要企業のプロファイルなどを調査しております。

第1章 分析概要

第2章 市場の概要と考察

  • 定義
  • アナリストの見解と現在の市場動向
    • 分析のポイント
    • 提言
    • 結論
  • 世界各国の規制状況

第3章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場機会

第4章 市場区分

  • 世界の分子診断市場:技術別
    • ポリメラーゼ連鎖反応 (PCR)
    • in situ ハイブリダイゼーション (ISH)
    • 質量分析 (MS)
    • DNAマイクロアレイ
    • 次世代シーケンシング (NGS)
    • 転写増幅 (TMA)
    • 核酸等温増幅方法
  • 世界の分子診断市場:製品別
    • 検査装置
    • 診断用試薬・キット
  • 世界の分子診断市場:用途別
    • 感染症
    • がん
    • 心血管疾患
    • 遺伝子検査
    • フォレンジック・サイエンス
    • 神経症
    • その他 (マイクロバイオロジー)
  • 世界の分子診断市場:エンドユーザー別
    • 病院
    • 診断センター
    • 研究機関

第5章 競争環境

  • 主要企業の分析
  • 主要戦略の分析

第6章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (英国、ドイツ、スペイン、フランス、イタリアなど)
  • アジア太平洋地域 (中国、日本、インドなど)
  • 他の国々 (RoW)

第7章 企業プロファイル

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • AltheaDX, Inc.
  • AutoGenomics, Inc.
  • Beckman Coulter, Inc.
  • Becton Dickinson and Co.
  • Biocartis N.V.
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • CareDX, Inc.
  • Danaher Corp.
  • ELITech Group
  • F. Hoffmann-La Roche, Ltd.
  • Genetic Technologies, Ltd.
  • GenMark Diagnostics, Inc.
  • Genomic Health, Inc.
  • Grifols, S.A.
  • Hologic, Inc.
  • HTG Molecular Diagnostics, Inc.
  • MDxHealth Group
  • Merck KGaA
  • Oxford Nanopore Technologies Ltd.
  • QIAGEN N.V.
  • Sequenom Laboratories
  • Siemens AG
  • Source BioScience UK Limited
  • Thermo Fisher Scientific, Inc.
  • Veracyte, Inc
図表

List of Tables

  • TABLE # 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 2 GLOBAL POLYMERASE CHAIN REACTION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 3 GLOBAL IN SITU HYBRIDIZATION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 4 GLOBAL MASS SPECTROMETRY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 5 GLOBAL DNA MICROARRAY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 6 GLOBAL NEXT GENERATION SEQUENCING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 7 GLOBAL TRANSCRIPTION MEDIATED AMPLIFICATION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 8 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT 2017-2023 ($ MILLION)
  • TABLE # 10 GLOBAL DIAGNOSTIC REAGENTS AND KITS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 11 GLOBAL TESTING EQUIPMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION ,2017-2023 ($ MILLION)
  • TABLE # 13 GLOBAL INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 14 GLOBAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 15 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 16 GLOBAL FORENSIC SCIENCE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 17 GLOBAL CARDIOVASCULAR DISEASES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 18 GLOBAL NEUROLOGICAL DISEASES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 19 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 20 GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY END-USER ,2017-2023 ($ MILLION)
  • TABLE # 21 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 22 GLOBAL RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 23 GLOBAL DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 24 GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHY 2017-2023 ($ MILLION)
  • TABLE # 25 NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 26 NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 27 NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
  • TABLE # 28 NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 29 NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 30 EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 31 EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 32 EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
  • TABLE # 33 EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 34 EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 35 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 36 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 37 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
  • TABLE # 38 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 39 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 40 REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 41 REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
  • TABLE # 42 REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 43 REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY TECHNOLOGY, 2017 VS 2023 (%)
  • FIGURE # 2 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY PRODUCT, 2017 VS 2023 (%)
  • FIGURE # 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY APPLICATION, 22017 VS 2023 (%)
  • FIGURE # 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY END-USER, 2017 VS 2023 (%)
  • FIGURE # 5 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
  • FIGURE # 6 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 7 UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 8 CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 9 EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 10 UK MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 11 GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 12 SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 13 FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 14 ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 15 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 16 ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 17 INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 18 CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 19 JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 20 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 21 REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: OMR2019507

Molecular diagnostics involves the application of a large array of techniques right from molecular biology to conducting a various test for analyzing biological markers in the genome and proteomes. The molecular diagnostic is used to keep close track of infectious disease, it's monitoring, risks involved and for various other purposes. The applicability of such diagnostic practice is highly in demand owing to the rising trend of personalized treatment and personalized medication. The major factor fueling the growth of the market is a rise in the prevalence of infectious diseases and also increasing cases of cancer across the globe. The demand for a cost-effective and accurate diagnostic solution is another factor propelling the growth of the market. On the contrary, the stringent laws and regulations related is the major factor restraining the growth of the market. The lack of adequate infrastructure in developing countries is one of the major hindrances in the growth of the market in emerging regions. The extended support of the government in terms of funding and technological advancement for the development of more precise and cost-effective diagnostic device will propel the market in future.

Based on the geography, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. The emerging countries such as India and China in the Asia-Pacific region is expected to grow significantly during the forecast attributed to the rapid development of the healthcare industry in such regions. North America holds the major share in the molecular diagnostics market owing to the presence of a large number of companies both in development and research of molecular diagnostic fields, the region also has the highest statistics related with cancer incidence. The European region follows North America in market share owing to the availability of well-established healthcare facility and increasing demand for personalized treatment.

The companies engaged in molecular diagnostics provides reagent kits and testing equipment for molecular diagnostic test. The market players also provide molecular diagnostic services for treatment and diagnosis of infectious diseases and cancer. The key players in the molecular diagnostics market are Becton Dickinson and Co., Abbott Laboratories, Inc., bioMerieux S.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Nanopore Technologies, QIAGEN N.V. and so on. The organizations such as Bio-Rad Laboratories, Inc. and Danaher Corporation, holds the major share of the molecular diagnostic market. The presence of a large number of companies makes the entire market highly competitive. An array of the organization is engaged in a clinical trial for applications of molecular diagnosis in personalized medicine development. Additionally, the organization such as Nanopore technologies has developed a point of care device which provides cost-effective sequencers.

Research methodology

The market study of the global molecular diagnostics market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Authentic Public Databases (org, gov and other such websites)
  • Whitepapers such as research papers and news blogs
  • Company websites and their product catalog.

The report is intended for researchers in the healthcare segment, emerging companies and researchers in the market, investing companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market segmentation

Global molecular diagnostics market is segmented on the basis of various regions and below mentioned segments:

  • 1. Global Molecular Diagnostics Market Research and Analysis by Technology
  • 2. Global Molecular Diagnostics Market Research and Analysis by Product
  • 3. Global Molecular Diagnostics Market Research and Analysis by Application
  • 4. Global Molecular Diagnostics Market Research and Analysis by End-user

The report covers:

  • Comprehensive research methodology of the global molecular diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global molecular diagnostics market.
  • Insights about market determinants which are stimulating the global molecular diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Definition
  • 2.2. Analyst Insights & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulation

3. Market Determinants

  • 3.1. Motivators
    • 3.1.1. Rising Prevalence of Infectious Diseases
    • 3.1.2. Extensive Application in Oncology
    • 3.1.3. Growing Number of FDA-Cleared and Approved Tests
    • 3.1.4. Growing Demand for Accurate and Cost-Effective Diagnostic Solutions
  • 3.2. Restraints
    • 3.2.1. Regulatory Issues and Hurdles
    • 3.2.2. Lack of Medical Infrastructure in Developing and Under Developed Countries
  • 3.3. Opportunities
    • 3.3.1. Growing Demand for Personalized Treatment
    • 3.3.2. Technological Advancement in Sequencing and Point of Care Testing Devices

4. Market Segmentation

  • 4.1. Global Molecular Diagnostics Market by Technology
    • 4.1.1. Polymerase Chain Reaction (PCR)
    • 4.1.2. In Situ Hybridization (ISH)
    • 4.1.3. Mass Spectrometry (MS)
    • 4.1.4. DNA Microarray
    • 4.1.5. Next-Generation Sequencing (NGS)
    • 4.1.6. Transcription Mediated Amplification
    • 4.1.7. Isothermal Nucleic Acid Amplification
  • 4.2. Global Molecular Diagnostics Market by Product
    • 4.2.1. Testing instruments
    • 4.2.2. Diagnostic Reagents and Kits
  • 4.3. Global Molecular Diagnostics Market by Application
    • 4.3.1. Infectious Diseases
    • 4.3.2. Cancer
    • 4.3.3. Cardiovascular Disease
    • 4.3.4. Genetic Testing
    • 4.3.5. Forensic Science
    • 4.3.6. Neurological Disease
    • 4.3.7. Other (Microbiology)
  • 4.4. Global Molecular Diagnostics Market by End-User
    • 4.4.1. Hospitals
    • 4.4.2. Diagnostic Centres
    • 4.4.3. Research Institute

5. Competitive Landscape

  • 5.1. Key Strategies
  • 5.2. Key Company Analysis

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Spain
    • 6.2.4. France
    • 6.2.5. Italy
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. Japan
    • 6.3.3. India
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. Agilent Technologies, Inc.
  • 7.3. AltheaDX, Inc.
  • 7.4. AutoGenomics, Inc.
  • 7.5. Beckman Coulter, Inc.
  • 7.6. Becton Dickinson and Co.
  • 7.7. Biocartis N.V.
  • 7.8. bioMerieux S.A.
  • 7.9. Bio-Rad Laboratories, Inc.
  • 7.10. CareDX, Inc.
  • 7.11. Danaher Corp.
  • 7.12. ELITech Group
  • 7.13. F. Hoffmann-La Roche, Ltd.
  • 7.14. Genetic Technologies, Ltd.
  • 7.15. GenMark Diagnostics, Inc.
  • 7.16. Genomic Health, Inc.
  • 7.17. Grifols, S.A.
  • 7.18. Hologic, Inc.
  • 7.19. HTG Molecular Diagnostics, Inc.
  • 7.20. MDxHealth Group
  • 7.21. Merck KGaA
  • 7.22. Oxford Nanopore Technologies Ltd.
  • 7.23. QIAGEN N.V.
  • 7.24. Sequenom Laboratories
  • 7.25. Siemens AG
  • 7.26. Source BioScience UK Limited
  • 7.27. Thermo Fisher Scientific, Inc.
  • 7.28. Veracyte, Inc
Back to Top